Hermann Koepsell

Active 1972–2024

90
Papers
20,087
Citations
76
h-index
88
i10-index

Citations

Citations per year for Hermann Koepsell1965: 1 citations1974: 3 citations1975: 2 citations1977: 2 citations1979: 1 citations1981: 3 citations1985: 1 citations1987: 4 citations1988: 1 citations1992: 1 citations1993: 19 citations1994: 29 citations1995: 28 citations1996: 25 citations1997: 61 citations1998: 100 citations1999: 88 citations2000: 113 citations2001: 141 citations2002: 118 citations2003: 158 citations2004: 213 citations2005: 210 citations2006: 186 citations2007: 169 citations2008: 181 citations2009: 121 citations2010: 190 citations2011: 206 citations2012: 170 citations2013: 233 citations2014: 192 citations2015: 193 citations2016: 200 citations2017: 215 citations2018: 201 citations2019: 590 citations2020: 718 citations2021: 773 citations2022: 545 citations2023: 379 citations2024: 528 citations2025: 245 citations2026: 2 citations1966–1973: no citations, so these years are not shown1976: no citations, so this year is not shown1978: no citations, so this year is not shown1980: no citations, so this year is not shown1982–1984: no citations, so these years are not shown1986: no citations, so this year is not shown1989–1991: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 1,636 citing papers, 25.4% of this breakdownChina: 565 citing papers, 8.7% of this breakdownGermany: 543 citing papers, 8.4% of this breakdownJapan: 417 citing papers, 6.5% of this breakdownUnited Kingdom: 399 citing papers, 6.2% of this breakdownCanada: 260 citing papers, 4% of this breakdownItaly: 212 citing papers, 3.3% of this breakdownNetherlands: 180 citing papers, 2.8% of this breakdownFrance: 166 citing papers, 2.6% of this breakdownSwitzerland: 144 citing papers, 2.2% of this breakdownAustralia: 143 citing papers, 2.2% of this breakdownSpain: 140 citing papers, 2.2% of this breakdown
0%25.4%Other 25.5%

Fields

  • Medicine59.7%
  • Biochemistry, Genetics and Molecular Biology17.9%
  • Neuroscience14.3%
  • Nursing2.3%
  • Pharmacology, Toxicology and Pharmaceutics1.2%
  • Agricultural and Biological Sciences1.1%
  • Other3.5%

Topics

  • Diabetes Treatment and Management7%
  • Drug Transport and Resistance Mechanisms6.8%
  • Pancreatic function and diabetes5.1%
  • Metabolism, Diabetes, and Cancer4%
  • Neuroscience and Neuropharmacology Research3.9%
  • Amino Acid Enzymes and Metabolism3.1%
  • Other70.1%

Coauthors

All papers

Open in search
  1. Glucose transporters in brain in health and disease

    Authors: - Pflügers Archiv - European Journal of Physiology 2020 cited by 534

  2. Functional expression of sodium-glucose transporters in cancer

    Authors: , , , , , , , , , , - National Academy of Sciences, Proceedings of the National Academy of Sciences 2015 cited by 329

  3. Glucose transporters in the small intestine in health and disease

    Authors: - Pflügers Archiv - European Journal of Physiology 2020 cited by 274

  4. Na+-d-glucose Cotransporter SGLT1 is Pivotal for Intestinal Glucose Absorption and Glucose-Dependent Incretin Secretion

    Authors: , , , , , , , , , , , , , , , , , , , , , , - Diabetes 2011 cited by 662

  5. SGLT2 Mediates Glucose Reabsorption in the Early Proximal Tubule

    Authors: , , , , , , , - Journal of the American Society of Nephrology 2010 cited by 561

  6. SGLT2 Protein Expression Is Increased in Human Diabetic Nephropathy

    Authors: , , , , , , , , , , , , , , , - Journal of Biological Chemistry 2017 cited by 302

  7. Organic Cation Transporters in Health and Disease

    Authors: - Pharmacological Reviews 2019 cited by 302

  8. SGLT2 inhibitor empagliflozin reduces renal growth and albuminuria in proportion to hyperglycemia and prevents glomerular hyperfiltration in diabetic Akita mice

    Authors: , , , , , , , , - American Journal of Physiology-Renal Physiology 2013 cited by 477

  9. SGLT2 inhibition and renal urate excretion: role of luminal glucose, GLUT9, and URAT1

    Authors: , , , , , , , , , , - American Journal of Physiology-Renal Physiology 2018 cited by 179

  10. Localizations of Na+-d-glucose cotransporters SGLT1 and SGLT2 in human kidney and of SGLT1 in human small intestine, liver, lung, and heart

    Authors: , , , , , , , , , , , , - Pflügers Archiv - European Journal of Physiology 2014 cited by 287

  11. Osmotic diuresis by SGLT2 inhibition stimulates vasopressin‐induced water reabsorption to maintain body fluid volume

    Authors: , , , , , , , - Physiological Reports 2020 cited by 132

  12. Knockout of Na-glucose transporter SGLT2 attenuates hyperglycemia and glomerular hyperfiltration but not kidney growth or injury in diabetes mellitus

    Authors: , , , , , , , , , - American Journal of Physiology-Renal Physiology 2012 cited by 369

  13. Increase in SGLT1-mediated transport explains renal glucose reabsorption during genetic and pharmacological SGLT2 inhibition in euglycemia

    Authors: , , , , , , , , - American Journal of Physiology-Renal Physiology 2013 cited by 303

  14. Polyspecific Organic Cation Transporters: Structure, Function, Physiological Roles, and Biopharmaceutical Implications

    Authors: , , - Pharmaceutical Research 2007 cited by 980

  15. The Na+-D-glucose cotransporters SGLT1 and SGLT2 are targets for the treatment of diabetes and cancer

    Authors: - Pharmacology & Therapeutics 2016 cited by 222

  16. The Role of SGLT1 and GLUT2 in Intestinal Glucose Transport and Sensing

    Authors: , , , , , - PLoS ONE 2014 cited by 400

  17. Sodium glucose cotransporter SGLT1 as a therapeutic target in diabetes mellitus

    Authors: , , , - Expert Opinion on Therapeutic Targets 2016 cited by 191

  18. Organic Cation Transporter 2 Mediates Cisplatin-Induced Oto- and Nephrotoxicity and Is a Target for Protective Interventions

    Authors: , , , , , , , , , , , , - American Journal Of Pathology 2010 cited by 441

  19. The SLC22 family with transporters of organic cations, anions and zwitterions

    Authors: - Molecular Aspects of Medicine 2013 cited by 380

  20. Cloning and expression of a rat brain L-glutamate transporter

    Authors: , , , , , , , , , - Nature 1992 cited by 1,238

  21. Expression of the Na+‐d‐Glucose Cotransporter SGLT1 in Neurons

    Authors: , , , , , , , - Journal of Neurochemistry 1997 cited by 134

  22. Cisplatin Nephrotoxicity Is Critically Mediated via the Human Organic Cation Transporter 2

    Authors: , , , , , , , , , - American Journal Of Pathology 2005 cited by 445

  23. Expression of Organic Cation Transporters OCT1 (SLC22A1) and OCT3 (SLC22A3) Is Affected by Genetic Factors and Cholestasis in Human Liver†

    Authors: , , , , , , , , , - Hepatology 2009 cited by 384

  24. Predominant role of active versus facilitative glucose transport for glucagon-like peptide-1 secretion

    Authors: , , , , , , - Diabetologia 2012 cited by 208